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Supported bilayerstitute an important part of the innate immune defense and are promising new
candidates for antibiotics. Naturally occurring antimicrobial peptides often possess hemolytic activity and are
not suitable as drugs. Therefore, a range of new synthetic antimicrobial peptides have been developed in
recent years with promising properties. But their mechanism of action is in most cases not fully understood.
One of these peptides, called V4, is a cyclized 19 amino acid peptide whose amino acid sequence has been
modeled upon the hydrophobic/cationic binding pattern found in Factor C of the horseshoe crab
(Carcinoscorpius rotundicauda). In this work we used a combination of biophysical techniques to elucidate
the mechanism of action of V4. Langmuir–Blodgett trough, atomic force microscopy, Fluorescence Correlation
Spectroscopy, Dual Polarization Interference, and confocal microscopy experiments show how the
hydrophobic and cationic properties of V4 lead to a) selective binding of the peptide to anionic lipids
(POPG) versus zwitterionic lipids (POPC), b) aggregation of vesicles, and above a certain concentration
threshold to c) integration of the peptide into the bilayer and ﬁnally d) to the disruption of the bilayer
structure. The understanding of the mechanism of action of this peptide in relation to the properties of its
constituent amino acids is a ﬁrst step in designing better peptides in the future.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Antimicrobial peptides are important components of innate
immune defense against a variety of microbial infections. They
directly target and permeate bacterial membranes eventually leading
to bacterial death. Due to the relative invariant nature of the bacterial
membrane components and its importance in protecting the microbe,
antimicrobial peptides which speciﬁcally target the bacterial mem-
brane have been considered promising drug candidates, as a subs-KVC by an internal disulﬁde
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l rights reserved.titute or addition to conventional antibiotics to which many
pathogens have acquired resistance [1–5].
Naturally occurring antimicrobial peptides are widely distributed
in host organisms including plants, insects, amphibians andmammals
[6–9]. Until now, more than 800 antimicrobial peptides have been
identiﬁed in eukaryotes (http://www.bbcm.units.it/∼tossi/amsdb.
html, Antimicrobial Sequences Database). Many antimicrobial pep-
tides display a broad spectrum of antimicrobial activity against
pathogens. For example, magainins show antimicrobial activity
against gram-positive bacteria, gram-negative bacteria, fungi, proto-
zoa and some viruses [10–12]. Gramicidin S has considerable
antimicrobial activity against gram-positive bacteria, gram-negative
bacteria and several fungi in liquid media [13,14]. However, a number
of antimicrobial peptides are also cytotoxic tomammalian cells, which
limits the direct use of these peptides as therapeutics. As a result, great
efforts are being made to modify the native antimicrobial peptides or
design new synthetic peptides to achieve better speciﬁcity against
microbial infections with the lowest side-effect on the host organism.
A variety of methods have been applied to design new antimicrobial
peptides based on the characteristics of the native peptides, such as
replacing some amino acid residues, changing the chirality of
peptides, hybridizing different peptide segments to form new
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bial peptides are usually short in length, which opens the possibility of
chemical peptide synthesis to realize the designed peptide.
Lipopolysaccharide (LPS), also known as endotoxin, is the major
component on the outer leaﬂet of the outer membrane of gram-
negative bacteria [23–26]. The study of endotoxin-binding host
defense proteins showed that an endotoxin-binding motif which
plays an important role in killing bacteria may be formed by
amphipathic sequences rich in cationic residues [27]. Therefore those
antimicrobial peptides which have strong ability to bind to
endotoxin and disrupt membranes have attracted extensive interest
for drug development. Frecer and colleagues made a de novo design
of antimicrobial peptides based on some sequences of endotoxin-
binding host defense proteins [28]. They designed a series of short
symmetric amphipathic peptides containing endotoxin-binding
sequence HBHPHBH and HBHBHBH (B: cationic residue; H: hydro-
phobic residue; P: polar residue) with a β-sheet conformation to
determine whether introduction of the endotoxin binding motif
could enhance the antimicrobial activities of cyclic cationic peptides.
Amongst these peptides, one named V4 is prominent (cyclized
CVKVQVKVGSGVKVQVKVC by the internal disulﬁde bond). V4 has a
good combination of high antimicrobial activity, low cytotoxic
activity and low hemolytic activity compared to other synthetic
and native peptides. V4 demonstrated a speciﬁcity 2400-fold greater
than that of Polymyxin B, which resulted from the higher level of
antimicrobial activity and the lower level of hemolytic activity of the
V4 peptide. Further study on the in vitro interaction between V4 and
lipid membranes, including different lipid components, shows that
besides the high binding afﬁnity for LPS and lipid A (the bioactive
part of LPS), V4 also displays a higher afﬁnity for negatively charged
phospholipids than for zwitterionic phospholipids. The strong
binding of V4 to the negatively charged lipids showed that elec-
trostatic force is a prerequisite for its selectivity on bacterial mem-
branes, in contrast to mammalian cell membranes [29]. Recently, we
have demonstrated in a comparison of several antimicrobial peptides
that V4 can aggregate lipid vesicles and can lead to vesicle leakage
[30]. However, a detailed explanation of its action has not been
attempted.
In the present study we investigate the action of V4 in binding and
disrupting membranes and compare its action to a truncated inactive
version of V4, called TV4. Different lipid membrane models were used
including lipid monolayers, solid supported bilayers and liposomes.
We combine several techniques: Langmuir Blodgett (LB) ﬁlm balance,
atomic force microscopy (AFM), dual polarization interferometry
(DPI), ﬂuorescence correlation spectroscopy (FCS) and confocal
imaging, to investigate the various steps of interaction between V4
and different membranemodels. At the same time, negatively charged
and zwitterionic phospholipids were used to examine the effect of
electrostatic and hydrophobic interactions on the action of V4 on the
membranes.
2. Materials and methods
2.1. Materials
Rhodamine 6G chloride (Rho 6G) and avidin are products from
Molecular Probes (ITS Science and Medical Pte Ltd., Singapore).
Triton-X100 and phosphate buffered saline (PBS, pH 7.4) were




Rhodamine B Sulfonyl) (Ammonium Salt) (Rho-PE), 1,2-Dipalmi-
toyl-sn-Glycero-3-Phosphoethanolamine-N-(7-nitro-2-1,3-benzoxa-
diazol-4-yl) (Ammonium Salt) (NBD-PE) and 1,2-Dipalmitoyl-sn-
Glycero-3-Phosphoethanolamine-N-(Cap Biotinyl) (Sodium Salt)(Cap Biotinyl-DPPE) were purchased from Avanti (Avanti Polar Lipids,
Inc., Alabaster, AL). V4 and V4-TMR which is the V4 labeled with dye
tetramethylrhodamine (TMR) at the N-terminus were synthesized by
Genemed (Genemed Synthesis, Inc., South San Francisco, CA). In
addition, we used a truncated V4 (TV4: VKVQVKVGSG) as a control
peptide (Genemed Synthesis). According to the HPLC data provided by
the company, the purity of V4-TMR was about 84% and the purity of
V4 was above 97%.
2.2. Interaction of V4 with lipid monolayers
2.2.1. Penetration study
The penetration study of V4 into monoloayers was performed on
a Langmuir ﬁlm balance (model 601 M, NIMA Technology Ltd.
England). The required volume of POPG or POPC chloroform solution
with a ﬁnal lipid concentration of 0.2 mM was spread on the water
surface in a drop-wise manner, making sure that the surface
pressure did not change after lipid deposition. After solvent
evaporation for 10 min, the monolayer was compressed to a target
surface pressure. The lipid monolayer was allowed to adjust until a
constant molecular area was achieved. Afterwards an appropriate
volume of V4 solution (dissolved in water with high concentration)
was injected underneath the monolayer into the subphase, generat-
ing different peptide concentrations in the trough. The surface
pressure change (Δπ) with time at a ﬁxed molecular area was
recorded.
2.2.2. AFM study
A lipid/V4 mixed monolayer formed in the LB trough was
transferred by a Langmuir Blodgett transfer to freshly cleaved mica.
For this purpose a mica plate is vertically placed in thewater subphase
of the LB trough before lipid was spread on thewater surface. After the
penetration experiment, the surface pressure was kept constant at the
surface pressure of complete penetration. The mica was slowly
extracted from the subphase. The monolayer on the mica was dried
in a desiccator overnight before AFM imaging.
AFM was performed in air on the NanoScope IIIa MultiMode
Scanning Probe Microscope (Digital Instruments Inc., Santa Barbara,
CA, USA). Topographic images were acquired in tapping mode. The
typical scan rates ranged from 1 to 1.25 Hz depending on the scan size.
The monolithic silicon probes (NanoWorld AG, Switzerland) with a
cantilever length of 125 μm and force constant of 42 N/m were used
for measurements. Images were obtained and analyzed by the
Nanoscope software provided by the company. Images from at least
two different samples prepared on different days with several
macroscopically separated areas on each sample were acquired for
data reproducibility.
2.2.3. Isotherm study
A Langmuir ﬁlm balance was used for isotherm studies of V4
interacting with lipid monolayers. POPG and POPC were dissolved in
chloroform with a concentration of 0.2 mM. Due to the low solubility
of V4 in chloroform, V4 was ﬁrst dissolved in the minimal volume of
methanol to prepare a clear solution. Additional chloroform was then
added to prepare a solution with a V4 concentration of 0.2 mM. The
required volume of POPG or POPC was mixed with V4 to form lipid/V4
mixture with V4 percentage of 0%, 5%,10%, 20%, 33%, 50% and 100%. An
appropriate volume of individual lipid/V4 mixed solution was
deposited on the water surface. The lipid monolayer formed spon-
taneously on the air-water interface in the absence or in the presence
of V4. After solvent evaporation for 10 min, the monolayer was
compressed and the isothermwas record. Each curve was repeated at
least twice for reproducibility.
The stability of a monolayer is determined by the excess Helmholtz
energy according to the method developed by Zhao and Feng [31,32].
The excess Helmholtz energy (ΔAexm ) was deﬁned as the deviation from





π12− X1π1 + X2π2ð Þ½ dA
A0 and A are the molecular area where the surface pressure begins
to increase from zero and where the Helmholtz excess energy is
calculated, respectively. π12, π1 and π2 are the surface pressure of
mixed monolayer, pure lipid monolayer and pure V4 monolayer at the
molecular area of A, respectively. X1 and X2 imply the percentage of
lipid and V4 respectively in the mixed monolayer.
2.3. Interaction of V4 with solid supported bilayer
2.3.1. Small unilamellar vesicles (SUVs) preparation
Lipids were prepared as stock solutions in chloroform. The solvent
was evaporated under N2 gas and then the samples were placed into
vacuum for at least 1 h. PBS buffer was added to re-dissolve the lipids to
give an aqueous suspensionwith a concentration of 0.5 mM. SUVswere
prepared by freeze— thawing the lipid suspension 5 times followed by
extrusion through 0.05 μm polycarbonate membrane ﬁlters 20 times
using a mini-extruder syringe device (Avanti Polar Lipids).
2.3.2. Insertion of V4 into solid supported bilayer as analysed by DPI
Dual polarization interferometry (DPI) was used to investigate the
interaction of V4 and TV4 with solid supported bilayers (POPG and
POPC). DPI is a surface based technique making use of functionalized
glass waveguides integrated into a ﬂow cell. Illuminating the stack of
waveguides produces an interference pattern which changes accord-
ing to the material deposited on the upper waveguide, allowing the
determination of opto-geometrical properties (mass, density and
thickness) of adsorbed layers at a solid-liquid interface [33–35].
Common optical biosensing techniques such as Surface Plasma
Resonance make use of singly polarized light to produce an
evanescent ﬁeld close to the solid liquid interface, and consequently
thickness (d) and refractive index (n) of material added at the solid
liquid interface cannot be measured independently. By contrast DPI
uses two different polarizations of light, termed Transverse Magnetic
(TM) and Transverse Electronic (TE), allowing the dimensions of an
adsorbed isotropic layer at the waveguide surface to be calculated
using a convergence algorithm ﬁtted to the measured phase changes
from the two polarizations [33,36].
In certain circumstances a surface layer will be formed from
uniaxial molecules where the polarisability along the length of the
molecule is different from across the molecule, such as liquid crystals.
Where these molecules are aligned with respect to the surface the net
angle of alignment will determine the extent to which the refractive
index of the layer is different if measured parallel or perpendicular to
the surface. Such an optically anisotropic overlayer will introduce an
additional unknown through the difference in the refractive index of
the layer as measured by the 2 polarizations TM and TE. In other
words, for an isotropic layer the refractive index of the layer as
measured by TM is the same as measured by TE, nTM= nTE, but for an
anisotropic layer nTM≠nTE. Failing to take account of the anisotropy of
the layer will result in the mis-reporting of measured opto-geometric
parameters, and will affect all optical techniques [37].
To analyze such an anisotropic layer one of the three parameters,
thickness (d), refractive index (n) or thedifference in layerRI, asmeasured
by TMas compared toTE (nTM–nTE) isﬁxed and the other twodetermined
from the measured changes in phase from the 2 polarizations.
A prime example of an anisotropic layer is a lipid bilayer, where the
alignment of lipids orthogonal to the solid substrate increases the
refractive index of the lipids as measured by TM compared to TE. The
assumption of an isotropic refractive index for the lipid layer would
lead to an over estimation of lipid layer thickness and mass.The data presented here is obtained by ﬁxing the thickness of the
lipid bilayer to be 4.0 nm, as determined by neutron scattering [38].
Assuming that this thickness is correct the obtained difference
nTM,–nTE will closely correspond to the birefringence of the overlayer.
A more strict deﬁnition of birefringence is the difference in
refractive index of the layer perpendicular (ne) and parallel (no) to the
surface. For the purposes described here it is sufﬁcient to describe
birefringence in terms of nTM-nTE [39].
In an example where a lipid layer moved from a less ordered to
more ordered (aligned) state the difference in refractive index of the
layer as measured by TM and TEwould increase and thus sowould the
reported birefringence. In the case where the alignment of the lipid
chains was disrupted, for example by an antimicrobial peptide
inserting into the lipid chains, the measured birefringence would
decrease. A peptide associating with the surface of a lipid layer, but not
inserting into the lipid layer would not be expected to signiﬁcantly
alter the measured birefringence of the layer.
To form lipid bilayers, liposomes were ﬂowed onto the glass
waveguide surface where the SUVs were allowed to deform and fuse
to form lipid bilayers [40]. Following establishment of stable layers
various concentrations of V4 and on a separate bilayer various
concentrations of TV4 were then ﬂowed over the bilayers with mass
and structural changes to the bilayer recorded.
2.4. FCS study of V4 and TV4 interacting with POPG REVs
FCS was used to investigate membrane permeation by V4 and TV4.
The preparation of POPG or POPC REVs and RLVs was described
previously [29,30,52]. The stock solution of POPG REVs was diluted
and mixed with different concentrations of V4 and TV4. The ﬁnal lipid
concentration was 40 μM. V4 concentrations were 1, 2, 5, 10, 15 and
20 μM with corresponding peptide:lipid ratio of 1:40, 1:20, 1:8, 1:4,
1:2.67 and 1:2. The concentrations of TV4 were 2, 20, 200 and
2000 μM. As control, 0.05% triton-X100 was also added to completely
disrupt REVs. FCS experiments were performed after 1 h incubation at
room temperature. The FCS instrument includes a Zeiss Axiovert 200
inverted microscope, an Argon-Krypton laser with a 515 nm line,
matching dichroic ﬁlter and emitter, highly sensitive avalanche
photodiodes (APD) detector. A dichroic ﬁlter (525DRLP) and an
emitter (545AF35) for REVs were used to separate the excitation
light from the emission ﬂuorescence.
Fluorescence correlation spectroscopy is a technique with single
molecule sensitivity [41]. It analyzes the ﬂuorescence intensity
ﬂuctuationwithin a tiny confocal volume due to theminute deviations
from thermal equilibrium. The detailed theory can be found in
literature[42–50]. For 3D diffusion processes, the measured ﬂuores-
cence photon count rates autocorrelation function (ACF) G(τ) can be
ﬁtted as follows:
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N is the average number of particles in the confocal volume. Qi, is
the ﬂuorescence yield of particle i. The coefﬁcients Fi are the mole
fraction of species i in the sample. τDi is the lateral diffusion time of
the ﬂuorescent particle staying in the confocal volume.ω and z are the
radial and axial distances of the confocal volume at which the
intensity has dropped by 1/e2 of the maximum value. G∞ is the
convergence value of the ACF for long times, in general this value is 1.
The program IgorPro (Wavemetrics, Lake Oswego, OR, USA) was used
to ﬁt the autocorrelation function to the experimental data as
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the confocal volume N are the two main parameters provided by FCS
for analysis. In a system with more than one ﬂuorescent species,
diffusion time, particle number in the confocal volume, and mole
fraction of each ﬂuorescent species can be distinguished by FCS.
2.5. Interaction of V4 with giant unilamellar vesicles (GUVs)
2.5.1. GUVs preparation
The POPG or POPC solution (5 mg/mL) was mixed with 3 mol% of
Cap Biotinyl-DPPE and 0.5% NBD-PE in chloroform. After evaporating
the sample by a rotary evaporator for 2 h, 2 mL water was added to
achieve a suspension of phospholipid with ﬁnal lipid concentration of
500 μM. This solution was incubated at 40 °C for 12 h. The lipid GUVs
formed spontaneously.
2.5.2. Immobilization of GUVs on coverslip
An avidin solution (0.5 mg/mL) was deposited on a cleaned
coverslip. After incubation for 15 min and air drying, lipid GUVs were
deposited on the avidin coated coverslip. The interaction between
avidin and biotin lead to the immobilization of GUVs on the coverslip.
2.5.3. Confocal imaging
In these experiments the ﬂuorescently labeled V4-TMR is used. The
labeling has limited inﬂuence on the antimicrobial activity of the
peptide, and V4-TMR shows similar properties as V4 and leads to
vesicle leakage at the same concentrations (data not shown). A GUVs
solution (250 μM)was ﬁrst premixedwith V4-TMR (0.5 μM) to achieve
amore homogenous distribution of V4-TMR on GUVs. After depositing
this mixture on the coverslip, unlabeled V4 was added and confocal
images were taken. Confocal imaging was performed on a Fluo-
ViewTM FV300 system with an Argon laser (488 nm) and HeNe laser
(543 nm) exciting NBD-PE and V4-TMR, respectively.
3. Results
3.1. Penetration of V4 into POPG and POPC monolayers
Lipid monolayers on the LB trough were compressed to a target
surface pressure of 15mN/m. Formeasurements of peptide actionon the
lipids, themonolayerwaskept at a constant surface area. The injection of
peptide into the subphase of the lipid monolayer induces a surface
pressure change, which indicates the binding or insertion of the peptide
into the lipidmonolayer. Fig. 1 shows the surface pressure increase (Δπ)
induced by the interaction betweenV4 and POPG and POPCmonolayers.
With the increase in V4 concentration, an increase in surface pressure is
observed until a peptide concentration of 0.5 to 1.0 μM at which theFig. 1. Langmuir–Blodgett trough experiments. The graph shows the surface pressure
increase (Δπ) induced by the interaction between V4 and POPG and POPC monolayers
on a Langmuir ﬁlm balance as a function of V4 concentration. At each peptide
concentration, V4 shows stronger afﬁnity for POPG than for POPC.interaction reached saturation. Further addition of V4 did not result in
any further increases of Δπ. V4 induced a higher surface pressure
increase Δπ on the negatively charged POPG monolayers compared to
the zwitterionic POPC monolayers at all concentrations.
3.2. AFM study of V4 penetrating into POPG and POPC monolayers
POPG and POPC monolayers in the absence or presence of V4 were
transferred ontomica and AFMwas performed to investigate the effect
of V4 on the morphology of the monolayers. The morphology of pure
POPG and POPC monolayers at the surface pressure of 15 mN/m is
shown in Fig. 2A and C. In the absence of peptide, the AFM images
displayed a regular and ﬂat area for both lipids, which indicated that
lipidmolecules formed a homogenousmonolayer. The section analysis
of POPG and POPCmonolayers provides the cross-section proﬁle of the
monolayers with regard to height difference. It can be observed that
the height difference of the pure lipidmonolayerwas 0.29 and 0.23 nm
for POPG and POPC, respectively. An increase of surface pressure up to
30mN/m did not affect themorphology of the puremonolayers which
stayed ﬂat with a height difference of 0.40 nm (data not shown).
Fig. 2B and D show the AFM images of monolayers of V4with POPG
and POPC, respectively. At peptide concentration of 50 nM, some thin
and long ﬁlaments which were randomly distributed protruding over
the monolayer surface were observed shown as bright regions. The
ﬁlaments illustrated in the ﬁgure were up to about 200 nm in length
and 10 nm inwidth. These protrusions were probably aggregates of V4
possibly in combination with lipids, which penetrated the monolayer,
strongly interacted with lipid molecules and accumulated on the
hydrophobic part of the POPG and POPC monolayers. The section
analysis of POPG and POPC monolayers with V4 penetration shows
that the height difference of the two arrows indicated on the two AFM
images is 1.53 and 0.94 nm, respectively. Besides the long ﬁlaments,
some small holes indicated by dark spots were also observed on the
POPG monolayer but not on the POPC monolayer. This conﬁrmed the
strong interaction between V4 and POPG, probably removing some
lipid molecules from the POPG monolayer. Fibril formation could also
be observed at concentrations of 500 nM and a surface pressure of
32 mN/m (data not shown). The three height levels detected on POPG
layers correspond to defects in the layers, the monolayer surface and
the ﬁbrils on accumulated on the hydrophobic part of the monolayer.
The formation of the ﬁlament structure upon interaction of V4 with
lipid monolayers is similar to previous accounts in literature. Plenat et
al. reported that some cell penetrating peptides form ﬁbrils with and
without lipids, self-associate and form supermolecular complexes to
perform their function [55].
3.3. Isotherm study of lipid/V4 monolayers
During compression isotherms of pure POPG and POPC began to
rise at a molecular area of 107 Å and 96 Å, respectively. With
increasing compression, the surface pressure increases continuously
until the collapse pressure of 45.8 ± 0.3 mN/m and 44.5 ±0.8 mN/m
for POPG and POPC, respectively. Both lipids, which have the same
hydrophobic tail groups and differ only in their hydrophilic head
groups, showed similar isotherms.
Pure V4 showed strong surface activity compared with the lipids.
At a molecular area of 125 Å, the isotherm of V4 began to rise. With
increasing compression, the surface pressure of V4 monolayer
continuously increased to 44.1 ± 1.9 mN/m, which was comparable
to the collapse pressure of POPG and POPC.
The isotherms of pre-mixed POPG/V4 and POPC/V4 monolayers
shifted right to higher molecular areas with increasing percentage of
V4. The surface pressure (π) and molecular area (A) isotherms of
premixed POPG/V4 and POPC/V4 are shown in Fig. 3. The collapse
pressure for all isotherms was similar except for the POPG/V4 mixture
with 50% V4 incorporation, which was an incomplete isotherm
Fig. 2. (A) Left: AFM topographic images of pure POPG monolayer. Right: Section analysis of pure POPG. The height difference indicated by the two arrows is 0.29 nm. (B) Left: AFM
topographic images of POPGmonolayer penetrated by 50 nMV4. Right: Section analysis of POPG/V4monolayer. The height difference indicated by the two arrows is 1.53 nm. (C) Left:
AFM topographic images of pure POPC monolayer. Right: Section analysis of pure POPC. The height difference indicated by the two arrows is 0.23 nm. (D) Left: AFM topographic
images of POPC monolayer penetrated by 50 nM V4. Right: Section analysis of POPC/V4 monolayer. The height difference indicated by the two arrows is 0.94 nm.
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served. Comparing all the molecular areas at which the surface pres-
sure began to increase (lift-off area), it is found that with increasing
incorporation of V4, the lift-off areas gradually increase for both lipids,
which indicates that V4 has an area-expanding effect on the lipid
monolayer at low surface pressure. It should be noted, that the POPG/
V4 mixtures of 20% and above reproducibly show a characteristic kink
in the isotherms indicating a change in the monolayer properties at
these concentrations.Fig. 4 shows the excess Helmholtz energy change at different
molecular areas. For both POPG and POPC, the presence of V4 in the
mixedmonolayer induced a negative deviation from ideal mixing. The
negative excess Helmholtz energy indicated that there is interaction
between lipid and V4, resulting in a lower energy of the stable system
[31,32]. With increasing percentage of V4 from 0 to 50%, the excess
Helmholtz energy continuously decreased, which indicates an increas-
ing interaction between lipid and V4 and a gradual increase in system
stability. The minimal excess energy, which corresponded to the most
Fig. 3. Isotherms of mixed POPG/V4 and POPC/V4 monolayers recorded on a Langmuir–
Blodgett trough with V4 percentage of 0%, 5%, 10%, 20%, 50% and 100% (corresponding
peptide/lipid ratio of pure lipid, 1:19, 1:9, 1:4, 1:1 and pure peptide).
Fig. 4. Excess Helmholtz energy of POPG and POPC monolayers incorporated with
different percentage of V4. (A) POPG; (B) POPC.
338 L. Yu et al. / Biochimica et Biophysica Acta 1788 (2009) 333–344stable systemwithin the studied V4 incorporation, was obtained in the
presence of 50%V4 in themixedmonolayer.WhenV4was incorporated
into the monolayer with the percentage from 0% to 50%, V4 increased
the system stability. The comparison of pre-mixed POPG/V4 and POPC/
V4monolayers shows comparable excessHelmholtz energies at 50% V4
incorporation. However at 10% and 20% V4 incorporation, V4 induced a
larger energy decrease for POPC than for POPG.
3.4. Interaction of V4 and TV4 with solid supported bilayers
Biological cell membranes are composed of lipid bilayers and
consequently one expects solid supported bilayers to more closely
resemble cell membranes compared to monolayers at an air-water
interface. Therefore the interaction of V4with solid supported bilayers
was investigated by DPI to explore the action of these peptides on
model membranes. The deposition of POPG and V4 were followed on
separate amine modiﬁed sensor chip surfaces. A 10 μM V4 solution,
corresponding to the maximum concentration used in these experi-
ments was injected into the sample chamber on a clean amine
modiﬁed sensor chip. Near zero non-speciﬁc binding was observed
and the surface coverage was measured at 0.054 ng/mm2. Compared
to V4, the addition of POPG SUVs to the amine surface led to high
surface coverage, with typical, coverage values N2.6 ng/mm2.
3.5. Stoichiometry of lipid: peptide interaction
Using a refractive index increment (RII) for lipid of 0.135 g/cm3
[51], the POPG layer (that was to be challenged with V4) had amass of 2.65 ng/mm2 or 3.437×10−12 moles/mm2. Using an RII of
0.184 g/cm3 for protein, the mass of V4 that bound to POPG during
the ﬁrst (4 μM) injection was 0.069 ng/mm2, which taking MW
of V4 as 2027 is 3.40×10−14 moles, giving a POPG:V4 stoichio-
metry of 101:1. Taking the total mass of V4 bound over all the
injections (0.414 ng/mm2) a stoichiometry of 16.8:1 was obtained
for POPG:V4.
For the POPG layer challengedwith TV4 themeasurements yielded
a mass of 2.74×10−9 g/mm2 or 3.55×10−12 moles/mm2. Mass of bound
TV4 during ﬁrst injection was 0.02×10−9 ng/mm2 and using a MW of
1042 for TV4 gives 1.92×10−14 moles and a POPG:TV4 stoichiometry of
185:1. Total mass of TV4 bound was 0.077 ng/mm2 and thus a
stoichiometry of 48:1.
3.6. Comparison of the mass and birefringence (alignment) changes
induced by V4 and TV4.
The dual polarization instrument has a dual ﬂuidic system
enabling a side by side comparison of the action of sample and
control. The data in Fig. 5A shows that at all added concentrations of
V4 the mass of V4 binding to POPG was signiﬁcantly greater than to
the control POPC layer. This is especially evident at the higher
concentrations of V4. The data also suggests the electrostatic
attraction of a PC bilayer is lower than for PG. The binding of V4 at
10 μM to PC is 19% of that compared to PG.
Fig. 5B shows the changes in mass and in the birefringence, i.e.
alignment within the lipid layer, during V4 and TV4 addition to POPG.
Addition of TV4 to the POPG bilayer showed no change in
birefringence strongly suggesting TV4 did not induce any change in
the alignment of the lipid tails. In contrast the addition of V4 showed a
signiﬁcant decrease in the birefringence of the POPG layer with each
injection of V4, indicating there is signiﬁcant disruption to the
alignment of the lipid chains induced by the insertion of the hydro-
phobic chains of V4.
Fig. 5. Dual polarization interferometry (DPI) experiments. (A) Change of mass
versus V4 concentration as injected on a POPG or POPC bilayer. The data shows
that V4 binding to POPG was greater than to the control POPC layer. (B) Mass and
birefringence changes when V4 or TV4 are added to POPG bilayers. The numbers in
the graph indicate the concentration in μM of V4 or TV4 added at different injections.
(C) Change in birefringence against mass of peptide for V4 and TV4. At a mass
of about 2.2 ng/mm2 the rate of change in birefringence increases for V4 indicat-
ing changes in alignment within the lipid layer. The dashed lines are guides for the
eyes.
Fig. 6. Normalized ACFs of peptides interacting with POPG REVs recorded at different
peptide:lipid ratios. The width of the ACF is an indicator for leakage. (A) V4
measurements: only at a concentration of V4:POPG=1:2 can leakage be observed.
After experiments Triton ×100 is added to disrupt the vesicles. (B) TV4 measurements:
even at peptide lipid ratios as high as 50:1, no leakage is observed.
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emphasizes the two stage process V4 undertakes on interacting with
POPG (Fig. 5C). The ﬁrst stage can be thought of as V4 accumulating on
the surface of POPG, whilst the second stage (N2.2 ng/mm2) correlates
with insertion across the whole bilayer. In other words there is a
threshold amount of V4 that must accumulate before signiﬁcant
insertion, (as evidenced by an increase in the rate of birefringence
change) is observed to take place.3.7. Membrane permeation and disruption
In a previous report we have given detailed information about
ﬂuorescence correlation spectroscopy (FCS) measurements of the
interaction of V4 with two different membrane models [30]. REVs
and rhodamine-PE labeled vesicles (RLVs) have been used to
determine whether V4 leads to membrane permeation, i.e. ﬂuor-
ophore leakage from REVs, and whether the permeation originates
from pore formation or membrane disruption, i.e. whether RLVs are
kept intact during vesicle leakage. Results clearly indicated that V4
leads to POPG vesicle leakage by a membrane disruptive process (at
a V4:lipid ratio of 1:2), in contrast to pore formation, and that before
vesicle disruption a step of vesicle aggregation can be detected at a
V4:lipid ratio of 1:2.67. On POPC vesicles V4 did not show any
changes up to V4:lipid ratios of 7.5:1. The ability of TV4, a control
peptide, to induce membrane permeation and disruption was
investigated here by ﬂuorescence correlation spectroscopy. REVs
were applied in this study to examine the effect of TV4 on the
integrity of membranes [52]. For the REVs, if the peptide induced
membrane permeation, Rho 6G, which was initially entrapped in the
vesicles, will be released into the solution, resulting in an increased
number of Rho 6G detected. The number of REVs, which are more
ﬂuorescent, will decrease, as well as its fraction. Simultaneously, due
to the release of ﬂuorescent dyes, the diffusion time of the
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number in the confocal volume N, contributed by both Rho 6G
particle number (Nrho) and POPG REVs (Nvesicle), together with the
diffusion time τD of the ﬂuorescent particle provides information
about membrane permeation or membrane disruption. In Fig. 6 we
show the results of TV4 measurements and show for comparison
previous results obtained with V4. In our previous study, V4 leads to
dye leakage from POPG LUVs at a V4:lipid ratio of 1:2. As control we
used TV4 with the same REV solution (Fig. 6B). Despite working at
peptide:lipid ratios of up to 50:1, no decrease in correlation time
could be detected and vesicles stayed intact.
3.8. Interaction of V4 with POPG and POPC GUVs
The GUVs were labeled with NBD-PE and were visualized with the
488 nm line of the confocal microscope. By contrast V4-TMR isFig. 7. Confocal images of V4 interacting with premixed POPC/V4-TMR and POPG/V4-TMRGU
TMR GUVs, excited by 488 nm and 543 nm laser, respectively. V4-TMR bound to the POPC G
GUVs. (C) was taken 2 s before V4 addition. (D) is the moment of V4 adding on GUVs. (E) wexcited by the 543 nm line. This double labeling strategy allows the
differentiation of lipid bilayers with and without V4 attached. Fig. 7A
shows a POPC GUV with a second vesicle inside. The image at
488 nm (A) shows both vesicles clearly due to the NBD-PE labeling.
The image at 543 nm (B) shows only the outer membrane due to
V4-TMR binding but no V4-TMR was detected in the inside of the
GUV. When unlabeled V4 (up to 25 μM) was added to this mixture,
V4-TMR was replaced and was removed from the POPC GUVs
without compromising the integrity of the vesicles. The replace-
ment of V4-TMR on the vesicle surface by the unlabeled V4 was
proven by Fig. 8, which showed a decrease in both photon count
rates and particle numbers on the POPC vesicle surface. In contrast,
V4 acted differently on POPG GUVs (Fig. 7C–E). Firstly, due to the
strong interaction between POPG GUVs and V4-TMR, the exchange
of peptide between membrane and surrounding buffer is slow,
which result in the inhomogeneous distribution of V4-TMR onVs. (A) and (B) show the interaction between V4 and premixed NBD-PE labeled POPC/V4-
UVs surface. (C) to (E) illustrate the process of V4 disrupting premixed POPG/V4-TMR
as taken 2 s after V4 addition.
Fig. 8. Interaction of V4 with premixed POPC/V4-TMR GUVs. The decrease in both
photon count rates and particle number in the confocal volume indicate the exchange
between V4 and V4-TMR on the membrane surface.
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drop) to POPG GUVs, V4 rapidly induced membrane disruption
within 2 s, which is in agreement with our previous FCS study on
LUVs [29].
4. Discussion
4.1. V4 action mechanism
Based on the combination of experiments on V4-membrane
interactions, we propose a possible action mechanism for V4. On a
molecular level V4 ﬁrst binds to the membrane surface due to
electrostatic interactions. It is the cationic character of the peptide
and thus the electrostatic forces which provide membrane selectivity
and the afﬁnity to allow peptide accumulation on the membrane.
This is shown by the lack of exchange of labeled against unlabeled
peptide on anionic lipid membranes and the binding studies in this
work by LB, DPI and FCS experiments. V4 caused obvious exchange
with V4-TMR on the POPC GUVs surface without entering the vesicle,
indicating that V4 ﬁrst binds to the membrane surface. This binding
is a dynamic equilibrium. LB experiments also showed that with
increasing V4 concentration, the surface pressure gradually
increased, caused by the absorption of V4 on the monolayer surface.
DPI experiments showed that V4 strongly binds to solid supported
lipid bilayers, indicating that V4 has strong absorbing ability on the
membrane. This process is mainly driven by electrostatic interaction.
However, electrostatic interactions are not sufﬁcient for membrane
permeation as is seen by experiments with the truncated control
peptide TV4, containing only one LPS binding motif (-VKVQVKV-),
which binds to POPG but lacks the ability to integrate and disrupt
POPG membranes. After absorption on the membrane surface, V4
oligomerizes or aggregates and inserts into the membrane, driven
mainly by hydrophobic interactions. This interpretation is supported
by the increase in the rate of change of birefringence in DPI
experiments after a threshold concentration of V4 (∼2.2 ng/mm2) is
reached. Further evidence of this might come from characteristic
changes in the Langmuir isotherms observed at POPG/V4 mixtures
with V4 concentrations of 20% and above. At these V4 concentrations
characteristic kinks were observed in the isotherms indicating
changes within the membrane. In addition, the continued change
in birefringence suggests that the peptide changes the membrane
structure probably due to insertion and translocation, and ﬁnally
leads to membrane disruption. Furthermore, circular dichroism
spectra of V4 in the presence and absence of POPG did not showany structural changes (unpublished results), excluding peptide
folding as a mechanism for membrane insertion. This supports the
hypothesis that aggregation or oligomerization is a necessary step
for antimicrobial activity for V4. AFM experiments also showed that
V4 caused some thin and long ﬁlaments protruding over the lipid
monolayer surface. These ﬁlaments have the size of up to about
200 nm long, probably due to the V4 aggregates interacting with
lipid. It should be noted that pure POPG monolayers did not change
structure at higher surface pressures of ∼30 mN/m and that ﬁbril
formation could be detected at the tested surface pressures from
15–30 mN/m. This indicates that the ﬁbril formation is not a result of
changes in lipid layer morphology due to surface pressure changes.
Because AFM scanned the hydrophobic chain part of the lipid
monolayer, the observation of the ﬁlaments indicated that V4 or V4
aggregates insert into the membrane, contact the hydrophobic chain
of the lipid and undergo translocation. After the translocation, V4
disrupts the membrane at a V4:lipid ratio of 1:2. Finally this step
causes bacterial death. We have shown previously, that V4 will
aggregate vesicles in solution before disruption and vesicle leakage
[30]. This is probably due to the high hydrophobicity of V4. At a high
peptide:lipid ratio, a large number of V4 which is cationic neutralizes
the negative charges of the vesicles, leading to a reduced electrostatic
repulsion. The hydrophobicity of V4 brings the vesicles together to
induce vesicle aggregation. However, as demonstrated by the confocal
experiments on immobilized GUVs, this is not an essential step and
membranes of immobilized vesicles will be disrupted in the absence of
vesicle aggregation. The process of V4 induced membrane permeation
and disruption is illustrated in Fig. 9. Firstly, V4 binds to or absorbs on
themembrane surface. Secondly, some of V4 insert into themembrane
and form peptide aggregates. After insertion, V4 traverses from the
membrane surface to the inner layer of the membrane and induce
membrane aggregation. Finally V4 disrupts the membrane, leading to
bacterial death. However, it is also possible that peptide translocation
and membrane aggregation happen simultaneously.
4.2. Effect of electrostatic interaction
Electrostatic forces play a signiﬁcant role in V4-membrane
interaction. The positive charges of V4 (4 lysines), similar to many
antimicrobial peptides, facilitate the electrostatic interaction with the
head groups of lipids consisting of negative charges and allow the
peptide to accumulate on the membrane even at low solution
concentrations. In contrast the reduced interaction with zwitterionic
POPC vesicles does not allow a sufﬁcient accumulation of the peptide
on the membrane to induce any further effects. LB experiments, FCS
measurements, DPI measurements and confocal imaging all support
this hypothesis. V4 has shown stronger absorption on POPG than
POPC monolayers in LB experiments. FCS demonstrated that V4
disrupts POPG LUVs at a peptide:lipid ratio of 1:2. However, even at a
peptide:lipid ratio of 7.5:1 no POPC vesicle disruption is observed.
The data from the DPI experiments supports the observation that V4
has much greater afﬁnity for POPG bilayers than POPC. The data in
Fig. 5 shows that at an added V4 concentration of 10 μM the PG layer
bound 0.44– 0.51 ng/mm2 compared to 0.16 ng/mm2 for PC at the
same V4 concentration. The binding of V4 to PC is 19% of that
compared to PG. In confocal imaging at the same peptide concentra-
tion of 25 μM, V4 showed only limited binding to POPC GUVs
whereas it strongly and rapidly interacted with POPG GUVs leading to
disruption. In addition, V4-TMR can be exchanged against unlabeled
V4 on POPC GUVs but not on POPG GUVs. These in vitro studies with
respect to the speciﬁcity of V4 provide the basis for the high
selectivity in killing bacteria, but not harming mammalian cells and
prove the in vivo ﬁndings of the previous study that V4 displayed a
combination of high antimicrobial activity, low cytotoxic activity and
low hemolytic activity with a greater speciﬁcity increase compared to
polymyxin B[28].
Fig. 9. Schematic drawing of the mechanism of V4 inducing membrane permeation. (A) Binding or absorption of V4 on the membrane surface. (B) Insertion of V4 intomembrane and
peptide aggregation. (C) Translocation of V4 into inner layer of membrane. (D) Membrane aggregation. (E) Membrane disruption. All graphs look at the bilayer in cross-section.
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Except electrostatic forces, hydrophobic forces also contribute to
V4-membrane interaction. Hydrophobic forces are important during
the insertion of V4 into the membrane. Although V4 has shown
stronger absorption on POPG than POPCmonolayer in LB experiments,
V4 also induced a considerable increase in POPC surface pressure,
which is contributed by hydrophobic interactions. In AFM studies, V4
induced similar ﬁlament formation on both lipid monolayers regard-
less of the charge of lipid, indicating the role of hydrophobic
interaction during the insertion of V4 into the hydrophobic tail
groups of lipids. The isotherm studies of the premixed V4/lipid
monolayer also show the role of hydrophobic interaction. For
example, at 50% V4 incorporation into the mixed V4/lipid monolayer,
the existence of V4 caused similar excess energy for both POPG and
POPC as shown in Fig. 4. The isotherm study was done on a premixed
peptide-lipid monolayer, excluding the binding or absorption process,and focused on the interaction within membranes. This result
indicates that the hydrophobic interaction plays an important role
during the peptide insertion into the membrane.
4.4. Membrane change induced by peptide
With increasing peptide binding, V4 begins to insert into the
membrane and undergoes translocation. This process is shown by
the penetration of V4 into lipid monolayers, detection of the
ﬁlaments on lipid monolayer and insertion into the solid supported
bilayer detected by Langmuir ﬁlm balance experiments, AFM and
DPI, respectively. Especially the DPI study of V4 interacting with
POPG bilayers showed that V4 induced an obvious increase in
bilayer mass and a concurrent decrease in layer birefringence,
consistent with a signiﬁcant disruption to the alignment of the lipid
tails within the bilayer. Each of the concentrations of V4 (4–10 μM)
induced a decrease in measured birefringence which was broadly
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higher concentrations of V4 where the initial sharp decrease in
birefringence is followed by a partial slower increase in birefrin-
gence, indicative of a re-ordering of the lipid chains to a slightly
more aligned conﬁguration following the initial chronic disruption
of the lipid chain alignment induced by V4. It should be noted that
the control peptide TV4, a truncated version of V4, lead neither to
vesicle leakage of REVs nor to the characteristic concentration
dependent change of birefringence in DPI, indicating that TV4 can
bind but not penetrate into the membrane.
4.5. The role of structure of V4
As control, we have applied TV4, which has only one binding site of
V4, to compare the ability of absorption and membrane disruption.
TV4 has shown much lower absorption on the solid supported POPG
bilayer than V4. The addition of TV4 to the POPG bilayer did not induce
any change in birefringence, indicating no change in the alignment of
the lipid tail. However V4 caused signiﬁcant decrease in the
birefringence of the POPG layer with V4 injection, suggesting a strong
disruption of V4 to the alignment of the lipid chains induced by the
peptide insertion. The FCS experiments also showed that TV4 did not
induce any POPG vesicle leakage and disruption up to peptide: lipid
ratio of 50:1, i.e. two orders of magnitude higher than the threshold
for V4 action, suggesting a lack of membrane disruption ability of TV4.
The difference in membrane disruption between TV4 and V4 is
probably due to the structural difference between them. V4 has two
binding sites (VKVQVKV) and is cyclized by an internal disulﬁde bond.
This structure might facilitate the aggregation of peptide and perform
its function. However, due to the lack of aggregation, TV4 shows no
membrane disrupting ability. This result is similar to that of S3, an
antimicrobial peptide from horseshoe crab. S3 dimer, which is
connected by two S3 monomers through an intermolecular disulﬁde
bond, has shown stronger ability to disrupt lipopolysaccharides (LPS)
micelles and neutralize LPS activity than S3 monomer did [53]. This
result is consistent with the observation that V4, which also contains a
disulﬁde bridge, shows membrane activity, while TV4 does not.
Therefore the disulﬁde bond and possibly more so the multiplicity of
endotoxin binding sites might play important roles in peptide
function.
5. Conclusion
Antimicrobial peptides are important potential antimicrobial
drugs and therefore the investigation of new peptide design and
their mechanisms acting on the membrane are subjects which have
elicited great interest. In this work, we have demonstrated the
combination of several approaches to examine the interaction of an
artiﬁcial novel antimicrobial peptide, V4, with different membrane
mimics to unravel the mechanism of this interesting peptide which
has shown high speciﬁcity and antimicrobial activity for some
microbes. This study provided the in vitro proof for the high selectivity
of V4. Electrostatic interaction and hydrophobic interaction have
different functions during antimicrobial interaction. Electrostatic
forces provide selectivity and afﬁnity to allow peptide accumulation
on the membrane above the surface concentration threshold above
which hydrophobic forces lead to insertion of V4 into the membrane.
The existence of a surface concentration threshold suggests that the
peptide integrates in an oligomeric or aggregated form. However, due
to the neutralization of charges during binding and the very strong
hydrophobicity of V4, the peptide leads as well to vesicle aggregation
before vesicle disruption takes place. While this effect can be desirable
when agglutination reduces bacterial growth, it is not essential since
immobilized vesicles can be disrupted without any vesicle aggrega-
tion. In addition, it would be advantageous to reduce V4 hydro-
phobicity to increase peptide solubility [29]. This study enhances theunderstanding of the predominant speciﬁcity of V4 and the mode of
action on membranes, and contributes to the rational design of novel
antimicrobial peptides, by suggesting the predominant contribution
of different amino acids to the action mechanism [54].
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